WallStSmart

Ainos Inc (AIMD)vsGarmin Ltd (GRMN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Garmin Ltd generates 41214196% more annual revenue ($7.46B vs $18,110). GRMN leads profitability with a 23.3% profit margin vs 0.0%. AIMD appears more attractively valued with a PEG of 0.93. GRMN earns a higher WallStSmart Score of 64/100 (C+).

AIMD

Avoid

25

out of 100

Grade: F

Growth: 2.7Profit: 2.5Value: 6.0Quality: 3.0
Piotroski: 3/9Altman Z: -6.39

GRMN

Buy

64

out of 100

Grade: C+

Growth: 7.3Profit: 8.0Value: 3.3Quality: 9.0
Piotroski: 5/9Altman Z: 5.27
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

Intrinsic value data unavailable for AIMD.

GRMNSignificantly Overvalued (-52.1%)

Margin of Safety

-52.1%

Fair Value

$135.80

Current Price

$236.57

$100.77 premium

UndervaluedFair: $135.80Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

AIMD2 strengths · Avg: 8.0/10
PEG RatioValuation
0.938/10

Growing faster than its price suggests

Price/BookValuation
2.1x8/10

Reasonable price relative to book value

GRMN5 strengths · Avg: 9.0/10
Debt/EquityHealth
0.0210/10

Conservative balance sheet, low leverage

Altman Z-ScoreHealth
5.2710/10

Safe zone — low bankruptcy risk

Profit MarginProfitability
23.3%9/10

Keeps 23 of every $100 in revenue as profit

Operating MarginProfitability
24.6%8/10

Strong operational efficiency at 24.6%

EPS GrowthGrowth
21.5%8/10

Earnings expanding 21.5% YoY

Areas to Watch

AIMD4 concerns · Avg: 3.3/10
EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$16.13M3/10

Smaller company, higher risk/reward

Profit MarginProfitability
0.0%3/10

0.0% margin — thin

Debt/EquityHealth
1.933/10

Elevated debt levels

GRMN2 concerns · Avg: 3.0/10
P/E RatioValuation
26.9x4/10

Moderate valuation

PEG RatioValuation
3.252/10

Expensive relative to growth rate

Comparative Analysis Report

WallStSmart Research

Bull Case : AIMD

The strongest argument for AIMD centers on PEG Ratio, Price/Book. PEG of 0.93 suggests the stock is reasonably priced for its growth.

Bull Case : GRMN

The strongest argument for GRMN centers on Debt/Equity, Altman Z-Score, Profit Margin. Profitability is solid with margins at 23.3% and operating margin at 24.6%. Revenue growth of 14.2% demonstrates continued momentum.

Bear Case : AIMD

The primary concerns for AIMD are EPS Growth, Market Cap, Profit Margin. Debt-to-equity of 1.93 is elevated, increasing financial risk.

Bear Case : GRMN

The primary concerns for GRMN are P/E Ratio, PEG Ratio.

Key Dynamics to Monitor

AIMD profiles as a value stock while GRMN is a mature play — different risk/reward profiles.

AIMD carries more volatility with a beta of 2.31 — expect wider price swings.

GRMN is growing revenue faster at 14.2% — sustainability is the question.

GRMN generates stronger free cash flow (469M), providing more financial flexibility.

Bottom Line

GRMN scores higher overall (64/100 vs 25/100), backed by strong 23.3% margins and 14.2% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Ainos Inc

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Ainos, Inc., a healthcare company, is dedicated to the development of medical technologies for safe and novel point-of-care testing and medical treatment for disease indications. The company is headquartered in San Diego, California.

Garmin Ltd

TECHNOLOGY · SCIENTIFIC & TECHNICAL INSTRUMENTS · USA

Garmin Ltd. is an American multinational technology company with headquarters in Olathe, Kansas.

Visit Website →

Want to dig deeper into these stocks?